Predictive, protective, orphan autoantibodies: The example of anti-phospholipid antibodies

Autoimmunity Reviews

Volumn 7, Issue 8, 2008, Pages 585-587

  Meroni, Pier Luigi ^a   Shoenfeld, Yehuda ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Anti phospholipid antibodies; Autoantibodies; Predictive value

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN CLASS; PHOSPHOLIPID ANTIBODY;

ANTIBODY TITER; ANTIGEN SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; BINDING AFFINITY; DISEASE MARKER; EDITORIAL; FETUS WASTAGE; HUMAN; NONHUMAN; RECURRENT DISEASE; RISK FACTOR; THROMBOGENICITY; THROMBOSIS;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; PHOSPHOLIPIDS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 50949114768     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.08.001     Document Type: Editorial

References (27)

1. Bizzaro N., Tozzoli R., and Shoenfeld Y. Are we at a stage to predict autoimmune rheumatic diseases?. Arthritis Rheum 56 (2007) 1736-1744
2. Fritzler M.J. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 7 (2008) 616-620 (This issue)
3. Shoenfeld Y., and Toubi E. Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthritis Rheum 52 (2005) 2599-2606
4. Oppezzo P., and Dighiero G. Autoantibodies, tolerance and autoimmunity. Pathol Biol (Paris) 51 (2003) 297-304
5. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
6. Galli M., and Luciani D. Lupus anticoagulants are stronger risk factors of thrombosis than anti-cardiolipin antibodies in the anti-phospholipid syndrome: a systematic review of the literature. Blood 101 (2003) 1827-1832
7. Galli M., Luciani D., Bertolini G., and Barbui T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102 (2003) 2717-2723
8. Galli M., Borrelli G., Jacobsen E.M., Marfisi R.M., Finazzi G., Marchioli R., et al. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood 110 (2007) 1178-1183
9. Carp H.J., Meroni P.L., and Shoenfeld Y. Autoantibodies as predictors of pregnancy complications. Rheumatology 47 Suppl 3 (2008) iii6-8
10. Opatrny L., David M., Kahn S.R., Shrier I., and Rey E. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 33 (2006) 2214-2221
11. Pierangeli SS, Chen PP, Raschi E, Scurati S, Grossi C, Borghi MO, et al., Antiphospholipid antibodies and the antiphospholipid syndrome: treatment and pathogenic mechanisms. Sem Trhromb Haemost in press.
12. De Laat B., Mertens K., and De Groot P.G. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism. Nat Clin Pract Rheumatol 4 (2008) 192-199
13. Ruffatti A., Tonello M., Cavazzana A., Bagatella P., and Pengo V. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res (2008) [Electronic publication ahead of print]
14. Meroni P.L. Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity. J Autoimmun 30 (2008) 99-103
15. Giannakopoulos B., Passam F., Rahgozar S., and Krilis S.A. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109 (2007) 422-430
16. Tincani A., Morozzi G., Afeltra A., Alessandri C., Allegri F., Bistoni O., et al. Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA). Clin Exp Rheumatol 25 (2007) 268-274
17. Haynes B.F., Fleming J., St Clair E.W., Katinger H., Stiegler G., Kunert R., et al. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308 (2005) 1906-1908
18. Cervera R. Lessons from the "Euro-Phospholipid" project. Autoimmun Rev 7 (2008) 174-178
19. Sodin-Semrl S., and Rozman B. Beta2-glycoprotein I and its clinical significance: from gene sequence to protein levels. Autoimmun Rev 6 (2007) 547-552
20. Kajiwara T., Yasuda T., and Matsuura E. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome. J Autoimmun 29 (2007) 164-173
21. Bagnasco M., Grassia L., and Pesce G. The management of the patient with unexpected autoantibody positivity. Autoimmun Rev 6 (2007) 347-353
22. Cavazzana I., Manuela N., Irene C., Barbara A., Sara S., Orietta B.M., et al. Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?. J Autoimmun 28 (2007) 160-164
23. Muscal E., and Myones B.L. The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun Rev 6 (2007) 215-217
24. Ambrozic A., Cucnik S., Tomsic N., Urbanija J., Lokar M., Babnik B., et al. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies. Autoimmun Rev 6 (2006) 10-15
25. Kiss E., Soltesz P., Der H., Kocsis Z., Tarr T., Bhattoa H., et al. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. J Autoimmunity 27 (2006) 211-217
26. Cervera R., Font J., Tincani A., and Boffa M.C. V Meeting of the European forum on antiphospholipid antibodies. Autoimmun Rev 5 (2006) 499-507
27. Languren M., Becerril B., Cabral A.R., Fernandez-Altuna L.E., Pascual V., Hernandez-Ramirez D.F., et al. Characterization of monoclonal anti-beta2-glcyoprotein-I and anti-prothrombin antibody fragments generated by phage display from a patient with primary antiphospholipid syndrome. J Autoimmmun 26 (2006) 57-65